TOP STORIES

• REGULATORY 4 Die after Taking SGLT-2 Inhibitors, Causality under Scrutiny
  October 15, 2014

• BUSINESS Parexel CEO Hails Rise of Partnership-Based Outsourcing in Japan
  October 14, 2014

• ACADEMIA St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
  October 10, 2014

• BUSINESS GSK to Market Authorized Generics through Aspen Japan Unit
  October 10, 2014

• REGULATORY MOF Panel to Pitch Reference Pricing for Long-Listed Drugs, Price Cut in FY2015
  October 9, 2014

• BUSINESS Shire Japan Takes Aim at $500 Million Sales in 10 Years
  October 8, 2014

• BUSINESS Chugai, Roche Chiefs Were in Talks on Recent Deal Change from 2 Years Ago
  October 7, 2014

• BUSINESS JCR Pharmaceuticals Hopes to Make Japan’s First Cell Product into New Profit Pillar
  October 6, 2014

• ORGANIZATION JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
  October 3, 2014

• BUSINESS MTPC Charges Ahead with Research Lab Overhaul to Buttress Drug Discovery
  October 2, 2014

• BUSINESS Novartis Pharma Notifies PMDA of Additional 1,299 Unreported Serious ADRs
  October 2, 2014

• BUSINESS Kissei to Spice Up Current Portfolio in Next 3 Years, Launch New Drugs Later
  October 1, 2014

• BUSINESS e-Detailing Powerhouse M3 to Establish New Firm Dedicated to CSO Biz
  September 30, 2014

• BUSINESS Avigan Administered to Ebola-Infected French Woman: Fujifilm
  September 29, 2014

• ORGANIZATION JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
  September 26, 2014

• BUSINESS Takeda to Invest 2.5 Billion Yen in US Firm for New Drug Development
  September 26, 2014

• BUSINESS AZ Managed to Speed Up Pilot R&D Projects under New Structure: President
  September 25, 2014

• TRENDS Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
  September 24, 2014

• BUSINESS Mediceo Sets to Increase Qualified Reps to 2,000, Enter Contract PMS Biz within 3 Years
  September 22, 2014

• REGULATORY MHLW Guidelines to Call for Thorough Internal Communications at Pharmas after Novartis’ Delayed ADR Reporting
  September 19, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 194
• 195
• 196
• 197
• 198
• 199
• 200
• 201
• 202
• …
• Next ›
• 最終 »